Dermafocus CeloraVita Launches in the UK

Leading regenerative aesthetics company DermaFocus has entered a new era in its history by announcing the launch of its first proprietary product, Celora Vita, a new injectable designed to support skin biorestoration at the source.

The introduction of Celora Vita marks the trusted industry distributor’s expansion from solely strategic distribution to include brand and category leadership, strengthening its already established portfolio of ground-breaking solutions, and reinforcing its commitment to shaping the future of regenerative aesthetics. It also brings the biorestoration category to the forefront of medical aesthetic innovation and advancement, offering medical aesthetics practitioners across the globe the opportunity to treat their patients at a completely new clinical level for the first time.

Developed to support skin biorestoration at the source, Celora Vita addresses substrate depletion within the extracellular matrix (ECM), an essential yet under-recognised contributor to skin ageing. As fibroblast activity declines with age, the availability of essential substrates required for collagen and elastin synthesis becomes increasingly limited. This reduction in amino acid availability contributes to impaired matrix renewal and progressive decline in skin quality.

Rather than volumising or altering facial features, Celora Vita is designed to restore building capacity at a dermal level, supporting physiological regeneration through targeted amino acid replenishment and optimisation of the extracellular environment. By focusing on restoring biological function rather than simply altering appearance, the launch of Celora™ Vita positions DermaFocus at the forefront of aesthetic innovation.

Co-Founder and Executive Director of DermaFocus, Milad Bemana, comments: “DermaFocus is committed to innovation and excellence in regenerative aesthetics. We are thrilled to be celebrating what is an exciting new chapter in our company’s history as we evolve from being exclusively a strategic distribution partner to becoming a brand owner and category leader with the launch of Celora™ Vita. While our business model is expanding, our customers and strategic partners can continue to expect the same high level of service and commitment they have always experienced. We remain focused on innovation, education, and delivering measurable clinical impact, and we look forward to shaping the future of regenerative aesthetics by introducing Celora™ Vita and the category of biorestoration to a global audience.”

Available now at Dermafocus.